ScholarIQanswers from OpenAlex & ORCID
Roberto Labianca
ResearcherPublications, citations & collaboration network
Roberto Labianca is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Roberto Labianca have?
ScholarIQindexed works
Roberto Labianca has 546 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Roberto Labianca have?
ScholarIQcitation count
Roberto Labianca has 39,524 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Roberto Labianca?
ScholarIQh-index
Roberto Labianca has an h-index of 82 in OpenAlex.
What is the i10-index of Roberto Labianca?
ScholarIQi10-index
Roberto Labianca has an i10-index of 268 in OpenAlex.
What is the ORCID of Roberto Labianca?
ScholarIQorcid
The ORCID for Roberto Labianca is on the source record.
What is the OpenAlex record for Roberto Labianca?
ScholarIQopenalex
The OpenAlex for Roberto Labianca is on the source record.
What are the most-cited papers on Roberto Labianca?
ScholarIQmost cited works
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
Axel Grothey, Alberto Sobrero, Anthony F. Shields, Takayuki Yoshino, James Paul, Julien Taı̈eb, John Souglakos, Qian Shi, Rachel Kerr, Roberto Labianca, Jeffrey A. Meyerhardt, Déwi Vernerey, Takeharu Yamanaka, Ioannis Boukovinas, Jeffrey P. Meyers, Lindsay A. Renfro, Donna Niedzwiecki, Toshiaki Watanabe, Valter Torri, Mark Saunders, Daniel J. Sargent, Thierry André, Timothy Iveson
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study
Giancarlo Agnelli, Gualberto Gussoni, C. Bianchini, Melina Verso, Mario Mandalà, Luigi Cavanna, Sandro Barni, Roberto Labianca, Franco Buzzi, Giovanni Scambia, Rodolfo Passalacqua, Sergio Ricci, Giampietro Gasparini, Vito Lorusso, Erminio Bonizzoni, Maurizio Tonato
Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies
F. Huguet, Thierry André, Pascal Hammel, Pascal Artru, Jacques Balosso, Frédèric Selle, Élisabeth Deniaud-Alexandre, Philippe Ruszniewski, E. Touboul, Roberto Labianca, Aimery de Gramont, Christophe Louvet